title: Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi.
abstract: Pathogens express ligands for several TLRs that may play a role in the induction or control of the inflammatory response during infection. Concerning Trypanosoma cruzi, the agent of Chagas disease, we have previously characterized glycosylphosphatidylinositol (GPI) anchored mucin-like glycoproteins (tGPI-mucin) and unmethylated CpG DNA sequences as TLR2 and TLR9 agonists, respectively. Here we sought to determine how these TLRs may modulate the inflammatory response in the following cell populations: F4/80(+)CD11b(+) (macrophages), F4/80(low)CD11b(+) (monocytes) and MHCII(+)CD11c(high) (dendritic cells). For this purpose, TLR2(-/-) and TLR9(-/-) mice were infected with Y strain of T. cruzi and different immunological parameters were evaluated. According to our previous data, a crucial role of TLR9 was evidenced in the establishment of Th1 response, whereas TLR2 appeared to act as immunoregulator in the early stage of infection. More precisely, we demonstrated here that TLR2 was mainly used by F4/80(+)CD11b(+) cells for the production of TNF-α. In the absence of TLR2, an increased production of IL-12/IL-23p40 and IFN-γ was noted suggesting that TLR2 negatively controls the Th1 response. In contrast, TLR9 was committed to IL-12/IL-23p40 production by MHCII(+)CD11c(high) cells that constitute the main source of IL-12/IL-23p40 during infection. Importantly, a down-regulation of TLR9 response was observed in F4/80(+)CD11b(+) and F4/80(low)CD11b(+) populations that correlated with the decreased TLR9 expression level in these cells. Interestingly, these cells recovered their capacity to respond to TLR9 agonist when MHCII(+)CD11c(high) cells were impeded from producing IL-12/IL-23p40, thereby indicating possible cross-talk between these populations. The differential use of TLR2 and TLR9 by the immune cells during the acute phase of the infection explains why TLR9- but not TLR2-deficient mice are susceptible to T. cruzi infection.
authors: Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
authors: Humberto D
authors: HD
authors: Gravina
authors: Lis
authors: L
authors: Antonelli
authors: Ricardo T
authors: RT
authors: Gazzinelli
authors: Catherine
authors: C
authors: Ropert
mesh_terms: D000210:Acute-Phase Reaction / Q000378:metabolism / Q000469:parasitology; D019264:Adoptive Transfer; D000818:Animals; D002478:Cells, Cultured; D014355:Chagas Disease / Q000276:immunology* / Q000378:metabolism / Q000469:parasitology; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000469:parasitology; D015870:Gene Expression; D006790:Host-Parasite Interactions; D018836:Inflammation Mediators / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000637:transplantation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology; D013154:Spleen / Q000276:immunology / Q000473:pathology; D051195:Toll-Like Receptor 2 / Q000502:physiology*; D051217:Toll-Like Receptor 9 / Q000819:agonists / Q000502:physiology*; D014349:Trypanosoma cruzi / Q000276:immunology*
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D009838:Oligodeoxyribonucleotides; C493486:Tlr2 protein, mouse; C495370:Tlr9 protein, mouse; D051195:Toll-Like Receptor 2; D051217:Toll-Like Receptor 9
references: PLoS One. 2010 Mar 26;5(3):e9896
references: 20360853
references: Eur J Immunol. 2011 Sep;41(9):2477-81
references: 21952800
references: J Leukoc Biol. 2010 Jul;88(1):189-99
references: 20360404
references: Infect Immun. 1996 Jan;64(1):128-34
references: 8557330
references: J Immunol. 2011 Apr 15;186(8):4925-35
references: 21398611
references: J Immunol. 2007 Apr 15;178(8):5192-9
references: 17404302
references: Nat Immunol. 2004 Oct;5(10):975-9
references: 15454920
references: J Immunol. 2004 Mar 1;172(5):2739-43
references: 14978071
references: J Immunol. 2008 Jul 15;181(2):1333-44
references: 18606688
references: EMBO J. 2000 Apr 3;19(7):1476-85
references: 10747016
references: Microbes Infect. 2009 Mar;11(3):321-7
references: 19146978
references: J Immunol. 2010 Jan 15;184(2):956-64
references: 20018612
references: Cell Immunol. 2007 Feb;245(2):103-10
references: 17521621
references: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5789-94
references: 19297619
references: Nat Rev Immunol. 2007 Mar;7(3):179-90
references: 17318230
references: J Immunol. 2006 May 15;176(10):5788-96
references: 16670284
references: Biochem Biophys Res Commun. 2007 Mar 23;354(4):1045-51
references: 17275788
references: J Immunol. 2004 Apr 15;172(8):4733-43
references: 15067049
references: Cell. 2010 Mar 19;140(6):805-20
references: 20303872
references: Pharmacol Rev. 2009 Jun;61(2):177-97
references: 19474110
references: J Immunol. 2009 Dec 1;183(11):6960-70
references: 19915052
references: J Immunol. 2010 Feb 1;184(3):1148-52
references: 20042586
references: Cell. 2002 Jul 26;110(2):191-202
references: 12150927
references: J Endotoxin Res. 2004;10(6):425-30
references: 15588426
references: Infect Immun. 1997 Feb;65(2):457-65
references: 9009297
references: Nat Med. 2009 Dec;15(12):1377-82
references: 19966777
references: Microbes Infect. 2004 Aug;6(10):946-59
references: 15310472
references: J Leukoc Biol. 2009 Apr;85(4):664-72
references: 19164128
references: Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):278-83
references: 21173242
references: J Parasitol Res. 2012;2012:507874
references: 22496959
references: J Immunol. 2001 Jul 1;167(1):416-23
references: 11418678
references: Eur J Immunol. 2010 Aug;40(8):2236-47
references: 20458705
references: Nat Rev Immunol. 2006 Dec;6(12):895-906
references: 17110955
references: Infect Immun. 1996 Jun;64(6):1961-7
references: 8675294
references: J Leukoc Biol. 2011 Apr;89(4):557-63
references: 21248152
references: J Immunol. 1997 Apr 1;158(7):3311-6
references: 9120288
references: Curr Biol. 2002 Mar 19;12(6):467-71
references: 11909531
references: Infect Immun. 1995 Dec;63(12):4862-7
references: 7591147
references: J Immunol. 2006 Sep 15;177(6):3515-9
references: 16951309
references: Curr Opin Immunol. 2003 Aug;15(4):396-401
references: 12900270